Vyne Therapeutics Inc (NASDAQ:VYNE)

0.3907
Delayed Data
As of May 16
 -0.0074 / -1.86%
Today’s Change
0.34
Today|||52-Week Range
4.24
-61.70%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 5.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +1,179.75% increase from the last price of 0.39.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Vyne Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$100.0K
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -272.50%
 
 
 
 
 
 
Growthannually 56.48%
 
 
 
 
 
 

Sales

Growthquarterly -43.82%
 
 
 
 
 
 
Growthannually -84.68%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.